Interact: A Mixed Reality Virtual Survivor for Holocaust Testimonies

In this paper we present Interact---a mixed reality virtual survivor for Holocaust education. It was created to preserve the powerful and engaging experience of listening to, and interacting with, Holocaust survivors, allowing future generations of audience access to their unique stories. Interact demonstrates how advanced filming techniques, 3D graphics and natural language processing can be integrated and applied to specially-recorded testimonies to enable users to ask questions and receive answers from that virtualised individuals. This provides a new and rich interactive narratives of remembrance to engage with primary testimony. We discuss the design and development of Interact, and argue that this new form of mixed reality is promising media to overcome the uncanny valley

A dynamical model of the local cosmic expansion

We combine the equations of motion that govern the dynamics of galaxies in the local volume with Bayesian techniques in order to fit orbits to published distances and velocities of galaxies within $\sim 3$ Mpc. We find a Local Group (LG) mass $2.3\pm 0.7\times 10^{12}{\rm M}_\odot$ that is consistent with the combined dynamical masses of M31 and the Milky Way, and a mass ratio $0.54^{+0.23}_{-0.17}$ that rules out models where our Galaxy is more massive than M31 with $\sim 95\%$ confidence. The Milky Way's circular velocity at the solar radius is relatively high, $245\pm 23$ km/s, which helps to reconcile the mass derived from the local Hubble flow with the larger value suggested by the `timing argument'. Adopting {\it Planck}'s bounds on $\Omega_\Lambda$ yields a (local) Hubble constant $H_0=67\pm 5$km/s/Mpc which is consistent with the value found on cosmological scales. Restricted N-body experiments show that substructures tend to fall onto the LG along the Milky Way-M31 axis, where the quadrupole attraction is maximum. Tests against mock data indicate that neglecting this effect slightly overestimates the LG mass without biasing the rest of model parameters. We also show that both the time-dependence of the LG potential and the cosmological constant have little impact on the observed local Hubble flow.Comment: 22 pages, 14 figures. Accepted to MNRAS. An error in the apex calculation (Appendix A) was found and has been fixed. The new constraints favour models where the Milky Way is less massive than M31. The rest of model parameters and conclusions remain unchange

Neuropathic pain in children

Lesions or disease of the somatosensory nervous system can produce neuropathic pain (NP). Typical features include spontaneous or paroxysmal pain, often described as burning, shooting, like electric shocks, or pins and needles. NP does occur in childhood, but age at the time of injury may influence the risk of NP following traumatic nerve injuries. Whilst conditions commonly associated with NP in adults may be less common in childhood (e.g., trigeminal neuralgia), other conditions (e.g., Fabry’s disease and erythromelalgia) may present with pain in childhood and provide a diagnostic challenge for paediatric practitioners

Intravenous opioids for chemotherapy-induced severe mucositis pain in children: Systematic review and single-center case series of management with patient- or nurse-controlled analgesia (PCA/NCA)

BACKGROUND: Chemotherapy-induced oral mucositis can result in severe pain. Intravenous (IV) opioids are recommended, but management protocols vary. We systematically reviewed studies reporting IV opioid use for pain related to chemotherapy-induced severe oral mucositis in children and conducted a large single-center case series. METHODS: Ovid MEDLINE, PubMed, and Cochrane databases were searched for studies reporting IV opioid duration and/or dose requirements for severe mucositis. Secondly, our pain service database was interrogated to describe episodes of opioid administration by patient- or nurse-controlled analgesia (PCA/NCA) for children with mucositis and cancer treatment-related pain. RESULTS: Seventeen studies (six randomized trials, two prospective observational, three retrospective cohort, six retrospective case series) included IV opioid in 618 patients (age 0.3–22.3 years), but reported parameters varied. Mucositis severity and chemotherapy indication influenced IV opioid requirements, with duration ranging from 3 to 68 days and variable dose trajectories (hourly morphine or equivalent 0-97 mcg/kg/h). Our 7-year series included PCA/NCA for 364 episodes of severe mucositis (302 patients; age 0.12–17.2 years). Duration ranged from 1 to 107 days and dose requirements in the first 3 days from 1 to 110 mcg/kg/h morphine. Longer PCA/NCA duration was associated with: higher initial morphine requirements (ρ = 0.46 [95% CI 0.35, 0.57]); subsequent increased pain and need for ketamine co-analgesia (118/364 episodes with opioid/ketamine 13.9 [9.8–22.2] days vs opioid alone 6.0 [3.9–10.8] days; median [IQR]); but not with age or sex. CONCLUSIONS: Management of severe mucositis pain can require prolonged IV opioid therapy. Individual and treatment-related variability in analgesic requirements highlight the need for regular review, titration, and management by specialist services

Primary Productivity in the Mid-Atlantic Bight: Is the Shelf Break a Location of Enhanced Productivity?

Estimates of primary production represent the input of carbon into food webs, as well as the initial step in the biological pump. For the past 60 years, much of the productivity information has been obtained using measurements of 14C-bicarbonate removal during simulated in situ incubations. However, such measurements often do not reflect the complexity of the environment, and also suffer from uncertainties, biases and limitations. A vertically resolved bio-optical model has been used to estimate productivity based on profiles commonly assessed in oceanographic investigations, but comparisons with simultaneous measurements of 14C-uptake are limited. We conducted three cruises off the coast of New England that included sampling continental shelf waters, the shelf-break region, and deeper waters at scales of 7 km, all of which had productivity estimated by a vertically resolved productivity model as well as by traditional 14C-uptake measurements using simulated in situ techniques. We found that the vertically resolved bio-optical model gave results that appear to be more robust and resolved productivity at smaller vertical and horizontal scales, and seem less biased by some of the uncertainties in 14C-uptake measurements. Both estimates suggest that the New England waters are highly productive due to a variety of biological and physical processes occurring at different times of the year, but there was no consistent stimulation at the shelf break over the time scales of these estimates

Standardising neonatal and paediatric antibiotic clinical trial design and conduct: the PENTA-ID network view.

Antimicrobial development for children remains challenging due to multiple barriers to conducting randomised clinical trials (CTs). There is currently considerable heterogeneity in the design and conduct of paediatric antibiotic studies, hampering comparison and meta-analytic approaches. The board of the European networks for paediatric research at the European Medicines Agency (EMA), in collaboration with the Paediatric European Network for Treatments of AIDS-Infectious Diseases network (www.penta-id.org), recently developed a Working Group on paediatric antibiotic CT design, involving academic, regulatory and industry representatives. The evidence base for any specific criteria for the design and conduct of efficacy and safety antibiotic trials for children is very limited and will evolve over time as further studies are conducted. The suggestions being put forward here are based on the adult EMA guidance, adapted for neonates and children. In particular, this document provides suggested guidance on the general principles of harmonisation between regulatory and strategic trials, including (1) standardised key inclusion/exclusion criteria and widely applicable outcome measures for specific clinical infectious syndromes (CIS) to be used in CTs on efficacy of antibiotic in children; (2) key components of safety that should be reported in paediatric antibiotic CTs; (3) standardised sample sizes for safety studies. Summarising views from a range of key stakeholders, specific criteria for the design and conduct of efficacy and safety antibiotic trials in specific CIS for children have been suggested. The recommended criteria are intended to be applicable to both regulatory and clinical investigator-led strategic trials and could be the basis for harmonisation in the design and conduct of CTs on antibiotics in children. The next step is further discussion internationally with investigators, paediatric CTs networks and regulators

Supramolecular structure in the membrane of Staphylococcus aureus

The fundamental processes of life are organized and based on common basic principles. Molecular organizers, often interacting with the membrane, capitalize on cellular polarity to precisely orientate essential processes. The study of organisms lacking apparent polarity or known cellular organizers (e.g., the bacterium Staphylococcus aureus) may enable the elucidation of the primal organizational drive in biology. How does a cell choose from infinite locations in its membrane? We have discovered a structure in the S. aureus membrane that organizes processes indispensable for life and can arise spontaneously from the geometric constraints of protein complexes on membranes. Building on this finding, the most basic cellular positioning system to optimize biological processes, known molecular coordinators could introduce further levels of complexity. All life demands the temporal and spatial control of essential biological functions. In bacteria, the recent discovery of coordinating elements provides a framework to begin to explain cell growth and division. Here we present the discovery of a supramolecular structure in the membrane of the coccal bacterium Staphylococcus aureus, which leads to the formation of a large-scale pattern across the entire cell body; this has been unveiled by studying the distribution of essential proteins involved in lipid metabolism (PlsY and CdsA). The organization is found to require MreD, which determines morphology in rod-shaped cells. The distribution of protein complexes can be explained as a spontaneous pattern formation arising from the competition between the energy cost of bending that they impose on the membrane, their entropy of mixing, and the geometric constraints in the system. Our results provide evidence for the existence of a self-organized and nonpercolating molecular scaffold involving MreD as an organizer for optimal cell function and growth based on the intrinsic self-assembling properties of biological molecules